As The Prevalence Of COPD Rises, So Will Demand For Nasal Cannulas, Boosting The Global Nasal Cannula Market Growth Over The Forecast Period
A nasal cannula is a device used to provide oxygen or increase the airflow of oxygen to a patient suffering from respiratory disease. This device is made up of lightweight plastic or silicon tubes that split into two prongs that are placed in the patient's nostrils to supply oxygen. This tube's other end is connected to an oxygen generator or flow metre. This nasal tube transports approximately 1–3 litres of oxygen per minute. It can vary depending on the needs of the patients. The rising prevalence of respiratory diseases will drive the nasal cannula market. According to a study published by the National Center for Biotechnology Information (NCBI) on September 29, 2020, 39 percent of COVID-19 patients suffered from acute respiratory distress syndrome, indicating a high need for providing oxygen needs for patients, which is expected to grow the nasal cannula market.
As the prevalence of copd rises, so will demand for nasal cannulas, boosting the global Nasal Cannula Market growth over the forecast period. The World Health Organization (WHO) estimates that approximately 65 million people worldwide suffer from mild to severe COPD, with approximately 3 million deaths each year. COPD is also the third leading cause of death in the world. According to the same source, acute lower respiratory tract infections kill approximately 4 million children under the age of five each year. Furthermore, preterm babies have been linked to complications associated with breathing issues. In 2018, nearly 15 million babies were born prematurely, according to the World Health Organization. Infants can be given precise ventilation using a nasal cannula. As a result of the rising prevalence of COPD in children and adults, the global nasal cannula market is expected to grow over the forecast period.
Because of the rise in the occurrence of respiratory diseases such as COPD and asthma, North America dominated the nasal cannula market and accounted for the largest revenue share of 41.1 percent in 2020. Chronic disease accounts for approximately 80 percent of health care expenditure. Furthermore, the expansion of local and international manufacturers facilitates the availability of low-cost products and adoption, propelling the nasal cannula market growth in the region. Asia Pacific, on the other hand, is expected to be the fastest-growing region during the forecast period due to the high percentage prevalence of asthma and COPD among the population, as well as the growing geriatric population. Growing healthcare expenditures and an increase in local manufacturers fuel the region's market growth.
Comments
Post a Comment